Immunogenicity and safety of three 2010-2011 seasonal trivalent influenza vaccines in Chinese toddlers, children and older adults: A double-blind and randomized trial

Human Vaccines and Immunotherapeutics

Volumn 9, Issue 8, 2013, Pages 1725-1734

  Luo, Feng Ji ^a   Yang, Li Qing ^a   Ai, Xing ^a   Bai, Yun Hua ^a   Wu, Jiang ^b   Li, Shu Ming ^a   Zhang, Zheng ^a   Lu, Min ^b   Li, Li ^a   Wang, Zhao Yun ^a   Shi, Nian Min ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b Beijing Centre for Diseases Prevention and Control   (China)

Author keywords

Immunogenicity; Influenza; Influenza A (H1N1); Safety; Seasonal trivalent influenza vaccine; Vaccine

Indexed keywords

INFLUENZA VACCINE;

ADULT; ARTICLE; CHILD; CHINESE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IMMUNOGENICITY; IMMUNOREACTIVITY; INFANT; INFECTION PREVENTION; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA VACCINATION; INJECTION SITE INDURATION; INJECTION SITE PAIN; INJECTION SITE PRURITUS; INJECTION SITE REACTION; INJECTION SITE SWELLING; MALE; MULTICENTER STUDY; MYALGIA; OUTCOME ASSESSMENT; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SINGLE DRUG DOSE; SYSTEMIC DISEASE; UNSPECIFIED SIDE EFFECT;

IMMUNOGENICITY; INFLUENZA; INFLUENZA A (H1N1); SAFETY; SEASONAL TRIVALENT INFLUENZA VACCINE; VACCINE;

AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; CHINA; DOUBLE-BLIND METHOD; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED;

EID: 84882978156     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.24832     Document Type: Article

References (20)

1. Bridges CB, Katz JM, Levandowski RA, Cox NJ. Inactivated influenza vaccines. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. Amsterdam: Elsevier Inc, 2008:259-90.
2. Fiore AE, Shay DK, Haber P, Iskander JK, Uyeki TM, Mootrey G, et al.; Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC). Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep 2007; 56(RR-6):1-54; PMID:17625497
3. World Health Organization. WHO position paper on influenza vaccines. Wkly Epidemiol Rec 2005; 33:279-87
4. World Health Organization. DG Statement following the meeting of the Emergency Committee. http://www.who.int/csr/disease/swineflu/4th-meeting-ihr/en/ index.html (accessed September 18, 2012)
5. Wu J, Xu F, Lu L, Lu M, Miao L, Gao T, et al. Safety and effectiveness of a 2009 H1N1 vaccine in Beijing. N Engl J Med 2010; 363:2416-23; PMID:21158658; http://dx.doi.org/10.1056/NEJMoa1006736
6. World Health Organization. H1N1 in post-pandemic period. http://www.who.int/mediacentre/news/state-ments/2010/h1n1-vpc-20100810/en/index. html (accessed September 18, 2012)
7. World Health Organization. Recommended viruses for influenza vaccines for use in the 2010-2011 northern hemisphere influenza season. Wkly Epidemiol Rec 2010; 85:81-92; PMID:20210260
8. Liang X F, Wang HQ, Wang JZ, Fang HH, Wu J, Zhu FC, et al. Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet 2010; 375:56-66; PMID:20018364; http://dx.doi.org/10.1016/S0140-6736(09)62003-1
9. Zhu FC, Wang H, Fang HH, Yang JG, Lin XJ, Liang X F, et al. A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med 2009; 361:2414-23; PMID:19846844; http://dx.doi.org/10.1056/NEJMoa0908535
10. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009; 325:197-201; PMID:19465683; http://dx.doi.org/10.1126/sci-ence.1176225
11. Langley JM, Scheifele DW, Quach C, Vanderkooi OG, Ward B, McNeil S, et al. Safety and immunogenicity of 2010-2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12-59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: a PHAC/CIHR Influenza Research Network (PCIRN) study. Vaccine 2012; 30:3389-94; PMID:22469860; http://dx.doi.org/10.1016/j.vac-cine.2012.03.046
12. Loebermann M, Anders G, Brestrich G, Fritzsche C, Klammt S, Boršo D, et al. Safety and immunogenicity of a trivalent single dose seasonal influenza vaccine containing pandemic A(H1N1) antigen in younger and elderly subjects: a phase III open-label single-arm study. Vaccine 2011; 29:1228-34; PMID:21167116; http://dx.doi.org/10.1016/j.vaccine.2010.11.092
13. Tregnaghi MW, Stamboulian D, Vanadía PC, Tregnaghi J P, Calvari M, Fragapane E, et al. Immunogenicity, safety, and tolerability of two trivalent subunit inactivated influenza vaccines: a phase III, observer-blind, randomized, controlled multicenter study. Viral Immunol 2012; 25:216-25; PMID:22691101
14. Künzel W, Engelmann H, D'Hondt E. Immune response to influenza vaccination. Lancet 1994; 343:173; PMID:7904017; http://dx.doi.org/10.1016/ S0140-6736(94)90962-8
15. Künzel W, Glathe H, Engelmann H, Van Hoecke C. Kinetics of humoral antibody response to trivalent inactivated split influenza vaccine in subjects previously vaccinated or vaccinated for the first time. Vaccine 1996; 14:1108-10; PMID:8911005; http://dx.doi.org/10.1016/0264-410X(96)00061-8
16. Cox RJ, Brokstad KA, Zuckerman MA, Wood JM, Haaheim LR, Oxford JS. An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination. Vaccine 1994; 12:993-9; PMID:7975853; http://dx.doi.org/10.1016/0264-410X(94)90334-4
17. European Committee for Proprietary Medicinal Products. Note for guidance on harmonisation of requirements for influenza vaccines (CPMP/BWP/214/96). European Agency for the Evaluation of Medicinal Products, 1997.
18. Division of Microbiology and Infectious Diseases. DMID pediatric toxicity tables. http://www.niaid.nih. gov/LabsAndResources/resources/DMIDClinRsrch/ Documents/dmidpedtox.pdf (accessed September 19, 2012)
19. Division of Microbiology and Infectious Diseases. DMID adult toxicity tables. http://www.niaid.nih. gov/LabsAndResources/resources/DMIDClinRsrch/ Documents/dmidadulttox.pdf (accessed September 19, 2012)
20. World Health Organization. WHO manual on animal influenza diagnosis and surveillance. Geneva: The World Health Organization 2002.